# BMP2-induced Adam12+ Fibroblasts Dictate Wound-associated Skin Scarring and Fibrosis

**Authors:** Jun-Yi Chen, Jin-Ru Song, Ke-Ai Li, Xue-Yan Xu, Ding-Heng Zhu, Lian Zhang, Zi-Shuo Chen, Qing Cheng, Liu-Yi Yao, Yi-Qi Shen, Zhili Rong, Bin Yang, Cheng-Cheng Deng

PMC · DOI: 10.7150/ijbs.123725 · 2026-02-04

## TL;DR

This study identifies a key role for Adam12+ fibroblasts in skin scarring and shows how BMP2 signaling controls their formation and function.

## Contribution

The study reveals BMP2 as a critical upstream signal for Adam12+ fibroblast generation and its role in skin scarring and fibrosis.

## Key findings

- BMP2 signaling is essential for generating Adam12+ fibroblasts from resident fibroblasts.
- Pharmacological inhibition of BMP2 reduces pathological scarring and fibrosis.
- BMP2, periostin, and Adam12+ fibroblasts are elevated in pathological scars.

## Abstract

Skin wounds typically undergo healing through scar formation, a fibrotic process mainly mediated by fibroblasts. Cumulative evidence from our group and others has established that Adam12+ fibroblasts were upregulated following skin injury and played a crucial role in scar formation. However, the molecular mechanisms governing the origin and pathogenesis of Adam12+ fibroblasts during skin scarring remain elusive. Here, we demonstrated that Adam12+ fibroblasts were necessary for wound-associated skin scarring and fibrosis. We identified BMP2 as the essential upstream signal for the generation of Adam12+ fibroblasts from resident fibroblasts and periostin as the key downstream effectors. Fibroblast-specific conditional knockout of BMP2 receptor significantly reduced Adam12+ fibroblast population, periostin expression, and ultimately skin scarring and fibrosis post-injury. BMP2, periostin and Adam12+ fibroblasts were found to be increased significantly in pathological scars compared with normal scars, and augmentation of BMP2 signaling expanded Adam12+ fibroblast population and exacerbated skin scarring and fibrosis, suggesting that BMP2 overexpression may contribute to pathological scarring. Pharmacological inhibition of BMP2 signaling markedly attenuated pathological scars. Taken together, our findings will help to understand skin fibrosis pathogenesis and provide potential targets for the therapy of pathological scars.

## Linked entities

- **Genes:** ADAM12 (ADAM metallopeptidase domain 12) [NCBI Gene 8038], BMP2 (bone morphogenetic protein 2) [NCBI Gene 650], postn (periostin, osteoblast specific factor) [NCBI Gene 100127174]

## Full-text entities

- **Genes:** En1 (engrailed 1) [NCBI Gene 13798] {aka En-1, Mo-en.1, engrailed-1}, Igfbp3 (insulin-like growth factor binding protein 3) [NCBI Gene 16009] {aka IGFBP-3, IGgfbp3}, Id3 (inhibitor of DNA binding 3) [NCBI Gene 15903] {aka Hlh462, Idb3, bHLHb25}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Postn (periostin, osteoblast specific factor) [NCBI Gene 50706] {aka A630052E07Rik, OSF-2, Osf2, PLF, PN}, POSTN (periostin) [NCBI Gene 10631] {aka OSF-2, OSF2, PDLPOSTN, PN}, ADAM12 (ADAM metallopeptidase domain 12) [NCBI Gene 8038] {aka ADAM12-OT1, CAR10, MCMP, MCMPMltna, MLTN, MLTNA}, ID1 (inhibitor of DNA binding 1) [NCBI Gene 3397] {aka ID, bHLHb24}, Id2 (inhibitor of DNA binding 2) [NCBI Gene 15902] {aka Idb2, bHLHb26}, Dlk1 (delta like non-canonical Notch ligand 1) [NCBI Gene 13386] {aka DLK-1, DlkI, FA1, Ly107, Peg9, SCP1}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Id1 (inhibitor of DNA binding 1, HLH protein) [NCBI Gene 15901] {aka D2Wsu140e, Idb1, bHLHb24}, Bmpr2 (bone morphogenetic protein receptor type 2) [NCBI Gene 12168] {aka 2610024H22Rik, BMP-2, BMPR-2, BMPR-II, BMPRII, BRK-3}, Bmpr1a (bone morphogenetic protein receptor, type 1A) [NCBI Gene 12166] {aka 1110037I22Rik, ALK-3, ALK3, BMPR-1A, BMPR-IA, Bmpr}, ID3 (inhibitor of DNA binding 3) [NCBI Gene 3399] {aka HEIR-1, bHLHb25}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, Bmpr1b (bone morphogenetic protein receptor, type 1B) [NCBI Gene 12167] {aka ALK-6, Acvrlk6, Alk6, BMPR-1B, BMPR-IB, CFK-43a}, Col11a1 (collagen, type XI, alpha 1) [NCBI Gene 12814] {aka C530001D20Rik, cho}, Epcam (epithelial cell adhesion molecule) [NCBI Gene 17075] {aka CD326, EGP, EGP-2, Egp314, Ep-CAM, EpCAM1}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Col3a1 (collagen, type III, alpha 1) [NCBI Gene 12825] {aka Col3a-1, Tsk-2, Tsk2}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Smad1 (SMAD family member 1) [NCBI Gene 17125] {aka Mad1, Madh1, Madr1, Mlp1, MusMLP, dwf-A}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, Prrx1 (paired related homeobox 1) [NCBI Gene 18933] {aka A230024N07Rik, K-2, MHox1, Pmx, Pmx1, Prx1}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, Adam12 (ADAM metallopeptidase domain 12) [NCBI Gene 11489] {aka 5830403F22Rik, Mltna}, Cd24a (CD24a antigen) [NCBI Gene 12484] {aka Cd24, HSA, Ly-52, nectadrin}, Kit (Kit proto-oncogene receptor tyrosine kinase) [NCBI Gene 16590] {aka Bs, CD117, Fdc, Gsfsco1, Gsfsco5, Gsfsow3}, COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, Pdgfra (platelet derived growth factor receptor, alpha polypeptide) [NCBI Gene 18595] {aka CD140a, Pdgfr-2}, ID2 (inhibitor of DNA binding 2) [NCBI Gene 3398] {aka GIG8, ID2A, ID2H, bHLHb26}, Runx2 (runt related transcription factor 2) [NCBI Gene 12393] {aka AML3, CBF-alpha-1, Cbf, Cbfa-1, Cbfa1, LS3}, Hbegf (heparin-binding EGF-like growth factor) [NCBI Gene 15200] {aka Dtr, Dts, Hegfl}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Dpp4 (dipeptidylpeptidase 4) [NCBI Gene 13482] {aka Cd26, Dpp-4, THAM}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Wnt1 (wingless-type MMTV integration site family, member 1) [NCBI Gene 22408] {aka Int-1, Wnt-1, sw, swaying}, ASPN (asporin) [NCBI Gene 54829] {aka OS3, PLAP-1, PLAP1, SLRR1C}, COL11A1 (collagen type XI alpha 1 chain) [NCBI Gene 1301] {aka CO11A1, COLL6, DFNA37, STL2}, Aspn (asporin) [NCBI Gene 66695] {aka 4631401G09Rik, Plap1, Slrr1c}, Rev3l (REV3 like, DNA directed polymerase zeta catalytic subunit) [NCBI Gene 19714] {aka Rev, Rev3, Sez4}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, Comp (cartilage oligomeric matrix protein) [NCBI Gene 12845] {aka TSP5}, Prdm1 (PR domain containing 1, with ZNF domain) [NCBI Gene 12142] {aka Blimp-1, Blimp1, PRDI-BF1, ZNFPR1A1, b2b1765Clo}
- **Diseases:** tissue injury (MESH:D017695), dislocation (MESH:D004204), Scarring (MESH:D002921), pathological (MESH:D005598), hypertrophic (MESH:D002312), fibrotic liver (MESH:D017093), cancer (MESH:D009369), Keloid (MESH:D007627), skin (MESH:D012871), skin injury (MESH:D000069836), tension (MESH:D018781), fibrotic diseases (MESH:D004194), wounding (MESH:D014947), hypertrophic scar (MESH:D017439), inflammatory (MESH:D007249), Fibrosis (MESH:D005355)
- **Chemicals:** formalin (MESH:D005557), ethanol (MESH:D000431), 4',6-diamidino-2-phenylindole (MESH:C007293), silicone (MESH:D012828), PBS (MESH:D007854), SDS (MESH:D012967), PVDF (MESH:C024865), bleomycin (MESH:D001761), TRIzol (MESH:C411644), citrate (MESH:D019343), LDN-193189 (MESH:C554430), Alexa Fluor 488 (MESH:C000711379), corn oil (MESH:D003314), Tamoxifen (MESH:D013629), beta-glycerophosphate (MESH:C031463), N (MESH:D009584), glycerol (MESH:D005990), hydrogen peroxide (MESH:D006861), 1xSDS (-), paraffin (MESH:D010232), Ethilon (MESH:D009757)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** NIH3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965140/full.md

---
Source: https://tomesphere.com/paper/PMC12965140